Market Research Logo

Oryzon Genomics S.A. (ORY) - Product Pipeline Analysis, 2016 Update

Summary

Oryzon Genomics S.A. (Oryzon) is a clinical stage biopharmaceutical company that offers development of epigenetics-based therapeutics. The company offers epigenetics, a regulatory system that controls gene expression without affecting the makeup of the genes themselves and provides regulation of gene transcription that has emerged as a key biological determinant of protein production and cellular differentiation. It provides therapeutic programs and collaborative research services. The company offers therapeutic programs for patients with cancers or neurodegenerative disorders. It offers genomics services to the pharmaceutical industry in Europe. Oryzon is headquartered in Cornella de Llobregat, Spain.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Oryzon Genomics S.A.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Oryzon Genomics S.A. Company Snapshot
Oryzon Genomics S.A. Company Overview
Oryzon Genomics S.A. Pipeline Products and Clinical Trials Overview
Oryzon Genomics S.A. – Pipeline Analysis Overview
Key Facts
Oryzon Genomics S.A. - Major Products and Services
Oryzon Genomics S.A. Pipeline Products by Development Stage
Oryzon Genomics S.A. Pipeline Products Overview
Diagnostic Assay - Alzheimer's Disease
Diagnostic Assay - Alzheimer's Disease Product Overview
Diagnostic Assay - Gastric Cancer
Diagnostic Assay - Gastric Cancer Product Overview
Diagnostic Assay - Melanoma Cancer
Diagnostic Assay - Melanoma Cancer Product Overview
Diagnostic Assay - Parkinson's Disease
Diagnostic Assay - Parkinson's Disease Product Overview
Diagnostic Assay - Stomach Cancer
Diagnostic Assay - Stomach Cancer Product Overview
OG-px
OG-px Product Overview
Oryzon Diagnostic Test - Prostate Cancer
Oryzon Diagnostic Test - Prostate Cancer Product Overview
Prognostic Assay - Gastric Cancer
Prognostic Assay - Gastric Cancer Product Overview
Prognostic Assay - Melanoma Cancer
Prognostic Assay - Melanoma Cancer Product Overview
Prognostic Assay - Ovarian Cancer
Prognostic Assay - Ovarian Cancer Product Overview
Prognostic Test - Colorectal Cancer
Prognostic Test - Colorectal Cancer Product Overview
Oryzon Genomics S.A. - Key Competitors
Oryzon Genomics S.A. - Key Employees
Oryzon Genomics S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Oryzon Genomics S.A., Recent Developments
Jan 26, 2016: Oryzon Genomics to Present at the Epigenetics in Drug Discovery Workshop
Dec 10, 2015: Oryzon Genomics Announces Listing on Madrid Stock Exchange
Nov 04, 2015: ORYZON Announces the Appointment of Mr. Antonio Fornieles, Ms. Isabel Aguilera and Mr. Ramon Adell as Independent Directors
Sep 17, 2015: Oryzon Shareholders Approve Listing to the Spanish Continuous Market
Sep 19, 2014: ORYZON reinforces its Board of Directors
Sep 14, 2011: Oryzon Genomics To Launch GynEC Dx Non Invasive Test For Detection Of Endometrial Cancer
May 17, 2011: Geadic Biotec Presents Results From Clinical Validation Of GynEC-Dx Test At SSGO 2011
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Oryzon Genomics S.A. Pipeline Products and Clinical Trials Overview
Oryzon Genomics S.A. Pipeline Products by Equipment Type
Oryzon Genomics S.A. Pipeline Products by Indication
Oryzon Genomics S.A., Key Facts
Oryzon Genomics S.A., Major Products and Services
Oryzon Genomics S.A. Number of Pipeline Products by Development Stage
Oryzon Genomics S.A. Pipeline Products Summary by Development Stage
Diagnostic Assay - Alzheimer's Disease - Product Status
Diagnostic Assay - Alzheimer's Disease - Product Description
Diagnostic Assay - Gastric Cancer - Product Status
Diagnostic Assay - Gastric Cancer - Product Description
Diagnostic Assay - Melanoma Cancer - Product Status
Diagnostic Assay - Melanoma Cancer - Product Description
Diagnostic Assay - Parkinson's Disease - Product Status
Diagnostic Assay - Parkinson's Disease - Product Description
Diagnostic Assay - Stomach Cancer - Product Status
Diagnostic Assay - Stomach Cancer - Product Description
OG-px - Product Status
OG-px - Product Description
Oryzon Diagnostic Test - Prostate Cancer - Product Status
Oryzon Diagnostic Test - Prostate Cancer - Product Description
Prognostic Assay - Gastric Cancer - Product Status
Prognostic Assay - Gastric Cancer - Product Description
Prognostic Assay - Melanoma Cancer - Product Status
Prognostic Assay - Melanoma Cancer - Product Description
Prognostic Assay - Ovarian Cancer - Product Status
Prognostic Assay - Ovarian Cancer - Product Description
Prognostic Test - Colorectal Cancer - Product Status
Prognostic Test - Colorectal Cancer - Product Description
Oryzon Genomics S.A., Key Employees
Oryzon Genomics S.A., Other Locations
List of Figures
Oryzon Genomics S.A. Pipeline Products by Equipment Type
Oryzon Genomics S.A. Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report